John Lunec
About
In The Last Decade
John Lunec
280 papers receiving 11.9k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Molecular Biology 5.9k
- Oncology 2.7k
- Cancer Research 2.1k
- Neurology 1.7k
- Nutrition and Dietetics 1.3k
Countries citing papers authored by John Lunec
This map shows the geographic impact of John Lunec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lunec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lunec more than expected).
Fields of papers citing papers by John Lunec
This network shows the impact of papers produced by John Lunec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lunec. The network helps show where John Lunec may publish in the future.
Co-authorship network of co-authors of John Lunec
This figure shows the co-authorship network connecting the top 25 collaborators of John Lunec. A scholar is included among the top collaborators of John Lunec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lunec. John Lunec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 7 | |
| 6 | 26 | |
| 7 | 41 | |
| 8 | 98 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | Increased susceptibility of MDM2 amplified cell lines to MDM2-p53 inhibitors is associated with a high turnover of MDM2 and p53 | 2 |
| 12 | Diet does not influence levels of urinary 8-hydroxy-2 '- deoxyguanosine or 8-hydroxyguanine in humans | 1 |
| 13 | 29 | |
| 14 | Measuring in vivo oxidative damage : a practical approach | 28 |
| 15 | Cyclin D1 expression in transitional cell carcinoma (TCC) of the bladder: Correlation with WAF1, p53 and Ki67. | 3 |
| 16 | Chemotherapy and muscle-invasive bladder cancer: Assessment of p53 immuno-reactivity (IR) as a predictor of response | 1 |
| 17 | Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor. | 22 |
| 18 | 23 | |
| 19 | 9 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.